Tracon Pharmaceuticals Inc (TCON)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0322 -0.0113 (-25.98%) 12/02/24 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0322 unch (unch) -
for Mon, Dec 2nd, 2024
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 8,564 | 17,433 | 24,072 | 32,131 | 16,412 |
Marketable Securities | N/A | N/A | N/A | 3,999 | 0 |
TOTAL | $9,090 | $18,228 | $24,936 | $36,914 | $17,260 |
Non-Current Assets | |||||
PPE Net | 37 | 51 | 50 | 16 | 23 |
Other Non-Current Assets | 978 | 1,190 | 1,571 | 508 | 838 |
TOTAL | $1,015 | $1,241 | $1,621 | $524 | $861 |
Total Assets | $10,105 | $19,469 | $26,557 | $37,438 | $18,121 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | N/A | 9,807 | 1,391 | 2,718 | 2,604 |
Accounts payable and accrued liabilities | 2,544 | 3,923 | 10,753 | 6,235 | 7,875 |
Accrued Expenses | 7,638 | 8,641 | 1,532 | 1,590 | 1,355 |
TOTAL | $10,182 | $22,371 | $13,676 | $10,543 | $11,834 |
Non-Current Liabilities | |||||
Long Term Debt | N/A | 3,280 | N/A | 1,391 | 2,739 |
aiOther Non-Current Liabilities | 732 | 969 | 1,167 | 432 | 850 |
TOTAL | $732 | $4,249 | $1,167 | $1,823 | $3,589 |
Total Liabilities | $10,914 | $26,620 | $14,843 | $12,366 | $15,423 |
Shareholders' Equity | |||||
Shares Outstanding, K | 2,275 | 1,191 | 981 | 774 | 270 |
Common Shares | 44 | 23 | 19 | 15 | 4 |
Retained earnings | -240,499 | -236,911 | -207,776 | -179,109 | -162,334 |
TOTAL | $-809 | $-7,151 | $11,714 | $25,072 | $2,698 |
Total Liabilities And Equity | $10,105 | $19,469 | $26,557 | $37,438 | $18,121 |